Abstract
Objective:
To describe the experiences of patients undergoing stent removal in the USDRN Study to Enhance Understanding of Stent-Associated Symptoms (STENTS), a prospective, observational cohort study of patients with short-term ureteral stent placement post-ureteroscopy.
Methods:
We conducted a qualitative descriptive study using in-depth interviews. Participants reflected on (1) painful or bothersome aspects of stent removal, (2) symptoms immediately after removal, and (3) symptoms in the days following removal. Interviews were audio-recorded, transcribed, and analyzed using applied thematic analysis.
Results:
The 38 participants interviewed were aged 13 to 77 years, 55% female, and 95% White. Interviews were conducted 7–30 days after stent removal. Almost all participants (n=31) described that they experienced either pain or discomfort during stent removal, but for most (n=25) pain was of short duration. Many participants (n=21) described anticipatory anxiety related to the procedure, and several (n=11) discussed discomfort arising from lack of privacy or feeling exposed. Interactions with medical providers often helped put participants at ease, but also increased discomfort for some. Following stent removal, several participants described lingering pain and/or urinary symptoms, but these largely resolved within 24 hours. A few participants described symptoms persisting for more than a day post stent removal.
Conclusions:
These findings on patients’ experiences during and shortly after ureteral stent removal, particularly the psychological distress they experienced, identify opportunities for improvement in patient care. Clear communication from providers about what to expect with the removal procedure, and the possibility of delayed pain, may help patients adapt to discomfort.
Keywords: Ureteroscopy, ureteral stent, removal, qualitative research, patients
INTRODUCTION
Ureteral stents are commonly used to maintain patency following ureteroscopic treatment of renal or ureteral stones.1,2 Although studies have shown that indwelling ureteral stents increase post-operative morbidity and negatively impact patients’ quality of life3,4, less is known about patients’ experiences with stent removal. Existing studies focus on patient preferences for various stent removal methods5,6 or assess patient perspectives on the removal process via quantitative measures.7,8 Missing are patients’ voices describing their experiences with stent removal.
We conducted qualitative interviews with patients enrolled in the nested qualitative cohort of the STudy to Enhance uNderstanding of sTent-associated Symptoms (STENTS).9 STENTS is a prospective, observational cohort study focused on enhancing understanding of patients’ stent-associated symptoms after ureteroscopy with short-term ureteral stent placement for the treatment of renal or ureteral stones and is part of the NIDDK-funded Urinary Stone Disease Research Network (USDRN). Participants were interviewed about their experiences with having a ureteral stent, including removal. Here we describe participants’ narratives on the ureteral stent removal process and their implications for patient care and future research.
MATERIALS AND METHODS
We conducted a qualitative descriptive study10,11 using in-depth interviews with adult and adolescent participants in STENTS. All participants had undergone ureteroscopy with stent placement for renal or ureteral stones; the type of stent used, dwell time, and removal method, followed usual clinical practice at each site. Trained qualitative interviewers conducted the interviews by telephone from March 28 to August 8, 2019. Focusing on the stent removal process, we asked participants to reflect on their experiences with (1) aspects of the removal that caused pain, discomfort, or were bothersome, including the type, location, and duration of pain, (2) symptoms experienced immediately after removal, defined as any symptoms experienced on the day of removal, and (3) symptoms experienced in the days following removal, including pain, bleeding, burning with urination, and other symptoms.
Interviews were audio-recorded with participants’ permission, transcribed verbatim following a transcription protocol12, and analyzed using applied thematic analysis13. Two analysts developed and independently applied structural codes14 (broad categories related to stent removal) to the transcripts, using NVivo (version 12)15, a qualitative data analysis software program. The analysts then identified content codes representing descriptions of specific participant experiences with stent removal and applied these to the text within each structural code. Inter-coder reliability assessments16 were conducted on 20% of transcripts at each stage of coding, and where necessary, discrepancies were resolved and codebooks and coding revised before proceeding to the next stage. The analysts then examined narratives within the content codes to identify common experiences among participant responses and wrote analytical summaries, including illustrative quotes, to describe participants’ experiences with the stent removal process and symptoms experienced after removal. Of note, although the most salient participant experiences describe characteristics of cystoscopic stent removal, perspectives of participants with extraction tethers were also included in the analysis.
The protocol was approved by an Institutional Review Board at each participating clinical center. Adult participants provided written consent, adolescents provided assent, and parents of adolescents provided permission.
RESULTS
Study participants
Of the 39 individuals who participated in NQC qualitative interviews, 38 spoke about stent removal. Participants were interviewed an average of 18 days following stent removal (range 7 to 30 days) and represented four geographically dispersed clinical sites. Participants’ ages ranged from 13 to 77 years, 55% (n=21) were female and 95% (n=36) were White (Table 1). Stent removal method varied among participants in accordance with usual clinical practice, such that some stents were removed with an extraction tether (18%, n=7) and others required removal via cystoscope (82%, n=31). Median stent dwell time was 8 days. Many participants stated that they received local anesthesia at the time of removal; no participants described that they were fully sedated.
Table 1.
Participant Demographics
| Characteristic | No. (%) n=38 |
|---|---|
| Age | |
| 12–17 | 2 (5) |
| 18–24 | 3 (8) |
| 25–34 | 7 (18) |
| 35–44 | 6 (16) |
| 45–54 | 8 (21) |
| 55–64 | 7 (18) |
| 65–74 | 4 (11) |
| 75+ | 1 (3) |
| Sex | |
| Female | 21 (55) |
| Male | 17 (45) |
| Race | |
| Black | 2 (5) |
| White | 36 (95) |
| Hispanic/Latino ethnicity | 3 (8) |
| Education | |
| Less than high school graduate | 3 (8) |
| High school graduate | 7 (18) |
| Some college or associate degree | 10 (26) |
| Bachelor’s degree | 14 (37) |
| Master’s or higher professional degree | 4 (11) |
| Employment status | |
| Unemployed/looking for work | 1 (3) |
| Student | 2 (5) |
| Working part-time | 4 (11) |
| Working full-time | 22 (58) |
| Retired | 6 (16) |
| Stay at home full-time | 2 (5) |
| Permanently disabled | 1 (3) |
| Marital status | |
| Single | 13 (34) |
| Married | 18 (47) |
| Divorced | 4 (11) |
| Widowed | 3 (8) |
| Geographic residence | |
| Mid-Atlantic | 6 (16) |
| Mid-West | 10 (26) |
| South West | 11 (29) |
| Pacific North West | 11 (29) |
| Clinical | |
| Stent dwell time (days) | |
| Median (IQR) | 8 (6.5, 11) |
| Mean (SD) | 10.1 (6.8) |
Participant experiences with stent removal
Pain and discomfort
Almost all participants (n=31) described experiencing either pain or discomfort at some point during stent removal, with slightly more reporting pain than discomfort. Participants who had pain often described the sensation as “burning” or “sharp,” and those who underwent cystoscopy commonly linked the occurrence of pain to the cystoscope advancing through the urethral sphincter or prostatic urethra. Pain was also reported during removal with a few participants commenting that they could feel the stent moving through their body or felt a “tugging” sensation. Participants who noted that the procedure was uncomfortable but not painful frequently characterized the sensation as “pressure.” Participant narratives highlighted three aspects that caused discomfort: insertion of the cystoscope into the urethra, searching for and grasping the stent within the bladder, and active pulling of the stent. While some participants said that pre-procedural local anesthesia helped to dull pain sensations, a few experienced discomfort related to the numbing procedure itself, describing that insertion of the anesthesia-containing syringe into the urethra was unpleasant and that the lidocaine burned upon application (Table 2, Section 1).
Table 2:
Participants’ symptom experiences
| Topic | Participant quote | |
|---|---|---|
| Section 1: Participant experiences with stent removal | ||
| Pain and discomfort | Pain |
|
| ||
| Discomfort |
|
|
| ||
| Pre-procedure |
|
|
| ||
| Nonphysical sources of discomfort | Anxiety |
|
| ||
| Prior expectations |
|
|
| ||
| Medical staff warned about pain |
|
|
| Did not know what to expect |
|
|
| Privacy |
|
|
| ||
| Medical providers – positive | Positive interaction |
|
| Draping |
|
|
| Communication during procedure |
|
|
| Viewed procedure/stent – positive |
|
|
| Medical providers – negative | Felt deceived about anesthesia |
|
| Dehumanizing experience |
|
|
| Viewed procedure/stent – negative |
|
|
| Section 2: Symptoms immediately following removal | ||
| Speed of removal |
|
|
| ||
| Symptom relief | Complete and lasting |
|
| Incomplete |
|
|
| Temporary |
|
|
| Pain |
|
|
| ||
| Bleeding |
|
|
| Burning with urination |
|
|
| Urinary urgency |
|
|
| ||
| Urinary frequency |
|
|
| Other symptoms |
|
|
| Section 3: Symptoms in the days after removal | ||
| Lingering symptoms |
|
|
| Pain |
|
|
| ||
| Urinary urgency |
|
|
Psychological responses
Many participants (n=21) described anxiety related to stent removal, commenting that they were “scared,” “afraid,” “fearful,” “nervous,” “anxious,” and “worried” about the procedure. Most shared being worried about the prospect of pain, although some participants elaborated that feelings of anxiety were also triggered by aspects of the medical setting, such as the sight of the removal equipment, or being awake and able to view the procedure on a monitor. Participants explained that prior expectations about stent removal influenced their feelings leading up to the procedure, with some expressing a general sense that removal would be unpleasant or “bad;” in some cases, participants expressed that previous experiences with stent removal or discussions with others ahead of time left them with the impression that stent removal would be a negative experience. Comments by medical personnel warning about the possibility of pain also contributed to this impression for a few participants; yet some participants who had not been informed about what to expect described that a lack of knowledge about the procedure led to misconceptions and further increased their anticipatory anxiety.
Eleven participants, all of whom underwent cystoscopy for stent removal, discussed discomfort arising from lack of privacy, embarrassment, or feeling exposed. Participants said that having their feet up in stirrups made them uncomfortable, particularly when they were left to wait in that position for several minutes while the anesthesia took effect, as did having their genitals cleaned and wiped with antiseptic. A small number of participants also commented that having opposite-gender medical personnel involved with the stent removal process was discomfiting (Table 2, Section 1).
Medical personnel interactions
Numerous participants (n=16) remarked on aspects of medical providers’ demeanor during the stent removal process, describing actions and comments that they found helpful or that, conversely, made them uncomfortable. Some participants who said they were nervous about the procedure commented that the way providers interacted with them prior to and during stent removal helped put them at ease. For example, participants described that clinic staff took extra care with draping to help them feel less exposed, and that providers communicated with them during the procedure, informing them of what was about to occur and coaching them on how they could relax their muscles to help the process. Several participants also appreciated being given the opportunity to watch the stent removal on a monitor or see the stent after it was removed, stating that they found this interesting and informative.
However, a few participants said they did not have a good experience with one or more members of the medical team. These participants largely felt that they had been deceived about aspects of the stent removal process, for example, about the amount of pain they would experience during the procedure or the type of anesthesia that would be available to them; one participant, who had not previously met the provider who performed the stent removal, described the experience as “dehumanizing.” Contrasting participants’ comments above, some participants said they felt uncomfortable when watching the stent removal or being shown the stent, noting that they would have appreciated being warned of what they were about to see (Table 2, Section 1).
Symptoms the day of removal
For most participants, any pain or discomfort experienced during stent removal was of short duration, as a majority of participants who spoke about speed of removal commented that the procedure was “quick and easy” (n=25), lasting from only a few seconds to under 5 minutes, and over half of participants described that they experienced immediate symptom relief. For some, relief was complete and lasting, while others noted incomplete or partial relief, with some symptoms improved but others, such as urinary urgency or pain, persisting for a day or more following removal. A few experienced immediate but temporary relief, reporting pain that subsided immediately upon stent removal, but returned within the first hour after the procedure.
A third of participants stated that they experienced pain on the day of stent removal, most commonly describing the sensation as “cramps” or “spasms” that were often located in the kidneys, back, or urethra. More than half of participants with pain indicated that it lasted less than 4 hours, but for a third of participants who reported post-removal pain, the sensation lingered between 24 and 48 hours. Of participants who described pain intensity, almost all stated that it was greater than or equal to the pain produced by the kidney stone, with the majority commenting that the pain was severe. High levels of post-removal pain also caused functional impacts, rendering participants temporarily unable to work, needing to lie down, and unable to get comfortable; a small number of participants said they went to or considered going to the emergency room. Participants who reached medical providers were told that their experience was an expected reaction to the procedure; in one case, a participant reported that the provider who performed the stent removal had predicted the timing and intensity of the participant’s post-removal pain experience almost exactly.
About a quarter of participants reported having bleeding and burning with urination on the day of stent removal. Most participants said these symptoms were mild, with bleeding lasting for only the first few voids after stent removal, or bleeding less severe than with the indwelling stent. Burning with urination largely subsided on the first day, with most participants who experienced burning noting that it occurred only for the first 1 to 3 voids after stent removal and was not bothersome. Several participants also described increases in urinary urgency, and a few described urinary frequency immediately after stent removal, which both resolved within the first day for the majority of participants; urinary urgency was primarily reported in the first minutes after the stent was removed. New symptoms also emerged for a few participants following stent removal, including fatigue, a temporary inability to pass urine, and a “phantom” sensation, as if the stent were still indwelling (Table 2, Section 2).
Symptoms in the days after removal
While a majority of participants experienced complete symptom relief within a day of stent removal, a third of participants reported that they were not entirely free from symptoms for 2 to 3 days to as long as 2 weeks following removal. Lingering symptoms included pain and discomfort, blood in the urine, and urinary urgency.
All participants with persistent symptoms in the days following stent removal described experiencing some type of pain. The majority reported feeling “discomfort” or a “dull ache;” however, a few described that their pain was severe, noting that they experienced cramps, spasms, or even pain similar to that of a kidney stone. These participants experienced functional impacts due to pain following stent removal, including inability to work and impaired sleep. Lingering pain was primarily described as being located in the bladder, flank, and kidneys and was most commonly experienced for 1 to 5 days after stent removal, gradually diminishing over time. A few participants, however, noted that their pain sensations lasted for a week or more. Pain was often described as episodic rather than constant and sometimes appeared to be triggered by movement or certain food and drink items. A few participants also saw blood in their urine over a multi-day period, although the amount was described as minimal, while others commented on lingering issues with urinary urgency and frequency (Table 2, Section 3).
DISCUSSION
To our knowledge, this is the first qualitative study to explore participant experiences with cystoscopic removal of a post-ureteroscopy ureteral stent. Our findings provide granular descriptions of participant experiences with pain related to stent removal, and importantly, reveal novel insights into these participants’ psychological distress. Specifically, participant narratives revealed feelings of anxiety prior to stent removal, as well as discomfort due to lack of privacy, embarrassment, or feeling exposed. Interactions with medical personal during the removal process were described as mitigating or exacerbating psychological distress; participants with lingering pain symptoms found them alarming and harmful to their quality of life. These findings give voice to patient concerns about the procedure in ways that are detailed, specific, and actionable.
Our findings complement reports of pain during the stent removal procedure as well as procedure-associated anxiety documented with other cystoscopic procedures. Loh-Doyle and colleagues surveyed patient experiences and preferences for ureteral stent removal via an anonymous web-based instrument (kidneystoners.org) with 571 participants and reported that 57% had moderate to severe pain levels of 4 or more out of 10 during stent removal,8 though the time between stent removal and survey response in this convenience sample was not reported. Other studies comparing stent removal pain via cystoscopy versus string removal reported that total mean visual analog scale (VAS) pain scores were higher for patients undergoing cystoscopy.5–7 In one of these studies, VAS scores were 5.67 out of 10 for the cystoscopy group and 2.73 for patients undergoing string removal.6 Lingering or delayed pain among patients following stent removal, like that reported by the interview participants, has also been demonstrated,8,17–19. Post-removal, pain has also been documented in 38%18 to 55%19 of patients and is sometimes of sufficient severity to cause patients to seek emergency medical treatment8. A recent randomized trial supports use of ketorolac to reduce pain and emergency department visits following stent removal.20
Kukreja and colleagues reported that among bladder cancer survivors who experienced moderate to severe discomfort with diagnostic cystoscopy, 78% considered procedure-associated anxiety to be a problem (though unable to differentiate procedure- and cancer-related anxiety),21 while Biardeau and colleagues found that 58% of patients who had office-based diagnostic cystoscopy reported some degree of anxiety prior to cystoscopy, and 22% experienced embarrassment.22
While practicing urologists may be familiar with patient anxiety during stent removal, our findings also shed light on opportunities for improving provider communication about the ureteral stent removal process and its aftermath. The survey by Loh-Doyle and colleagues revealed that patients placed high priority on being informed about the stent removal process, rating it at 4.6 on a scale of 1 to 5, with 5 being “very important,” and Kukreja and colleagues described that many patients were interested in being involved with medical planning to reduce cystoscopy discomfort. In our interviews, some participants described that knowing what to expect during the procedure helped them to feel less anxious. Likewise, some participants in our research reported that lack of clarity or mixed messaging about the procedure led them to imagine worst-case scenarios prior to undergoing the procedure and elevated their pre-procedural worry and anxiety.
Biardeau and colleagues summarize guidance on optimal pre-procedural counseling and suggest that providers should consider the vocabulary used, avoid pain-related words,23,24, emphasize clarity over volume of information,25 and make use of standard written materials for educating patients.26 They further propose that for procedures involving only local anesthesia, providers should communicate with patients while the procedure is underway;27 indeed, several of the participants in our study remarked that providers’ communication helped put them at ease during stent removal. Counseling patients about the possibility of pain following stent removal may also be helpful;8 in their clinical practice, Theckumparampil and colleagues routinely engage in preoperative counseling about post-stent removal symptoms, including reassurance that most patients are able to return to baseline activity levels by the day following stent removal.18 Based on our interview data, we propose potential topics for provider messaging that may be helpful in setting patient expectations for ureteral stent removal (Table 3).
Table 3.
Potential messaging topics for providers to guide patient expectations for ureteral stent removal
| Pre-procedure |
|
| During the procedure |
|
| Post-procedure |
|
Lastly, our findings suggest an important unmet clinical and research need for patient-reported experience measures (PREMs) for stent removal, concomitant with efforts to reduce psychological distress. PREMs reflect perceptions of the experience of care, and provide information helpful for improving patient experience, which is an indicator of quality. Systematic assessment of patient experience with stent removal and structured effort to reduce psychological distress may help to mitigate the burdens of stone treatment.
Our study has both strengths and limitations. By conducting interviews within 30 days of stent removal, we were able to limit recall bias. Further, the geographic diversity of our sample enabled us to capture variations in clinical practice that may occur between centers, thus reflecting commonalities in patient experience. Limitations include the purposeful selection process such that a different group of participants may have recounted different experiences as well as the limited racial and ethnic diversity of the study population. Daily symptom scores following ureteroscopy with stent have been reported for this nested cohort,28 and are similar in the entire STENTS cohort.29 The perspectives primarily pertain to stent removal by cystoscopy, and may be less salient to removal without cystoscopy (e.g., by tether). In this observational study, practices such as pre-cystoscopy counseling were not standardized across the study, in order to gain insights from practice variation. In addition, we lack granular procedural data for the stent removal (e.g., lidocaine use); many of the patient-reported impacts, such as lack of privacy and psychological stress, would not be impacted by these clinical factors.
However, our findings, particularly relative to the occurrence of post-stent pain, are reflective of other published studies on stent removal.
CONCLUSION
Our findings revealed that participants not only experience pain and physical discomfort with the removal of post-ureteroscopy ureteral stents but also psychological distress, and some experience lingering pain or urinary symptoms, described qualitatively herein and quantified by daily symptom measurement.28 Urologists may be able to mitigate psychological discomfort during the stent removal procedure through education and communication, with particular focus on topics that may reduce anticipatory anxiety and manage expectations for the process, including symptomatology following stent removal. Development of PREMs and systematic efforts to improve the stent removal experience appear indicated.
Funding Information
This research was supported by the National Institutes of Health/NIDDK, as follows: U01DK110988 (Duke University - Al-Khalidi, Scales), U01DK110954 (University of Washington - Harper, Wessells), U01KD110986 (Washington Univ. St Louis - Desai, Lai), U01DK110994 (UT Southwestern – Maalouf), and U01DK110961 (UPenn/CHOP - Reese).
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Urinary Stone Disease Research Network: The following individuals were instrumental in the planning and conduct of the STENTS study at each of the participating institutions:
Clinical Centers
University of Pennsylvania/Children’s Hospital of Pennsylvania, Philadelphia, PA: PI: Peter P Reese, MD, MSCE, Gregory E. Tasian, MD MSCE, CoIs: Justin Ziemba, MD MSEd. Study Coordinators: Emily Funsten, Adam Mussell, Rebecca McCune, Salima Shah, Arushi Jain, Antoine Selman-Fermin.
University of Texas Southwestern Medical Center, Dallas, TX: PI: Naim M. Maalouf MD, Jodi A. Antonelli MD. Co-I: Brett A. Johnson MD, Margaret S. Pearle, MD PhD, Linda A. Baker MD. Study Coordinators: Brooke Piskator, Joyce Obiaro, Cynthia Rangel, Martinez Hill. University of Washington, Seattle, WA: PI: Jonathan D. Harper, MD, Hunter Wessells, MD; Co-I: Michele Curatolo MD, Todd Edwards PhD, Mathew Sorensen MD, Collaborator: Robert Sweet, MD. Study Coordinators: Tristan Baxter, Holly Covert, Elsa Ayala, Lisa Flint. Washington University in St. Louis, St. Louis, MO: PI: Alana C. Desai, MD, H. Henry Lai, MD; Co-Is: Kefu Du, MD; Study Coordinators: Susan Mueller RN, Linda Black RN, Aleksandra Klim RN.
Scientific Data Research Center
Duke Clinical Research Institute, Duke University, Durham, NC: PI: Charles D. Scales, Jr MD MSHS, Hussein R. Al-Khalidi PhD. Co-I: Amy Corneli, PhD, Bryce Reeve, PhD, Kevin Weinfurt, PhD. Statistician: Honqiu Yang, PhD. STENTS Project Lead: Davy Andersen. USDRN Project Lead: Laura Johnson. Lead CRA: Andrew Dodd. Data Manager: Omar Thompson. Qualitative Research Core: Carrie Dombeck, Kevin McKenna, Teri Swezey.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Project Scientist: Ziya Kirkali, MD; Program Official: Christopher Mullins, PhD.
Declaration of Competing Interest
Author Specify “No Conflict” or indicate specific conflict
e.g. John Doe no conflict
e.g. Jane Doe paid consultant to company “x”
1)__Carrie Dombeck No conflict__________________________
2)__Charles D Scales Jr (study funding NIDDK) _______________________
3)___Kevin McKenna No conflict _________________________
4)___Teresa Swezey No conflict___________________________________
5)___Jonathan D. Harper (study funding NIDDK) _____________________
6)___Jodi A. Antonelli (study funding NIDDK) _______________________
7)___Alana C. Desai (study funding NIDDK) _________________________
8)___Rebecca McCune (study funding NIDDK) _______________________
9)___H. Henry Lai (study funding NIDDK) ___________________________
10)__Michele Curatolo ((study funding NIDDK) ______________________
11) Hussein R. Al-Khalidi (study funding NIDDK)
12) Peter P. Reese (study funding NIDDK)
13) Hunter Wessells (study funding NIDDK)
14) Ziya Kirkali (no conflicts)
15) Amy Corneli (study funding NIDDK)
I accept the responsibility for the completion of this document and attest to its validity on behalf of the co-authors.
_Charles D. Scales, Jr
REFERENCES
- 1.Auge BK, Sarvis JA, L’Esperance JO, Preminger GM. Practice Patterns of Ureteral Stenting after Routine Ureteroscopic Stone Surgery: A Survey of Practicing Urologists. J Endourol. 2007;21(11):1287–1292. doi: 10.1089/end.2007.0038 [DOI] [PubMed] [Google Scholar]
- 2.Pereira JF, Bower P, Jung E, et al. Ureteral stenting practices following routine ureteroscopy: an international survey. World J Urol. 2019;37(11):2501–2508. doi: 10.1007/s00345-019-02660-7 [DOI] [PubMed] [Google Scholar]
- 3.Joshi HB, Stainthorpe A, MacDonagh RP, Keeley FX, Timoney AG. Indwelling Ureteral Stents: Evaluation of Symptoms, Quality of Life and Utility. J Urol. 2003;169(3):1065–1069. doi: 10.1097/01.ju.0000048980.33855.90 [DOI] [PubMed] [Google Scholar]
- 4.Leibovici D, Cooper A, Lindner A, et al. Ureteral Stents: Morbidity and Impact on Quality of Life. Isr Med Assoc J. 2005. Aug;7(8):491–4. [PubMed] [Google Scholar]
- 5.Barnes KT, Bing MT, Tracy CR. Do ureteric stent extraction strings affect stent-related quality of life or complications after ureteroscopy for urolithiasis: a prospective randomised control trial. BJU Int. 2014;113(4):605–609. doi: 10.1111/bju.12541 [DOI] [PubMed] [Google Scholar]
- 6.Inoue T, Okada S, Hamamoto S, et al. Impact of ureteric stent removal by string on patient’s quality of life and on complications at post-ureteroscopy for urolithiasis: a controlled trial. BJU Int. 2019;124(2):314–320. doi: 10.1111/bju.14622 [DOI] [PubMed] [Google Scholar]
- 7.Kim DJ, Son JH, Jang SH, Lee JW, Cho DS, Lim CH. Rethinking of ureteral stent removal using an extraction string; what patients feel and what is patients’ preference? : a randomized controlled study. BMC Urol. 2015;15(1):121. doi: 10.1186/s12894-015-0114-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Loh-Doyle JC, Low RK, Monga M, Nguyen MM. Patient Experiences and Preferences with Ureteral Stent Removal. J Endourol. 2015;29(1):35–40. doi: 10.1089/end.2014.0402 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Scales CD, Lai HH, Desai AC, et al. Study to Enhance Understanding of Stent-Associated Symptoms: Rationale and Study Design. J Endourol. 2021;35(6):761–768. doi: 10.1089/end.2020.0776 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Sandelowski M Whatever happened to qualitative description? Res Nurs Health. 2000;23(4):334–340. doi: 10.1002/1098-240x(200008)23:4<334∷aid-nur9>3.0.co;2-g [DOI] [PubMed] [Google Scholar]
- 11.Sandelowski M What’s in a name? Qualitative description revisited. Res Nurs Health. 2010;33(1):77–84. doi: 10.1002/nur.20362 [DOI] [PubMed] [Google Scholar]
- 12.McLellan E, MacQueen KM, Neidig JL. Beyond the Qualitative Interview: Data Preparation and Transcription. Field Methods. 2003;15(1):63–84. doi: 10.1177/1525822X02239573 [DOI] [Google Scholar]
- 13.Guest G, MacQueen K, Namey E. Applied Thematic Analysis. SAGE Publications, Inc.; 2012. doi: 10.4135/9781483384436 [DOI] [Google Scholar]
- 14.Saldana J The Coding Manual for Qualitative Researchers. Fourth Edition. SAGE Publications, Inc.; 2021. Accessed October 27, 2021. https://us.sagepub.com/en-us/nam/the-coding-manual-for-qualitative-researchers/book273583 [Google Scholar]
- 15.NVivo. QSR International Accessed October 27, 2021. https://www.qsrinternational.com/nvivo-qualitative-data-analysis-software/about/nvivo
- 16.O’Connor C, Joffe H. Intercoder Reliability in Qualitative Research: Debates and Practical Guidelines. Int J Qual Methods. 2020;19:1609406919899220. doi: 10.1177/1609406919899220 [DOI] [Google Scholar]
- 17.Rezaee ME, Vollstedt AJ, Yamany T, et al. Stent duration and increased pain in the hours after ureteral stent removal. Can J Urol. 2021;28(1):10516–10521. [PubMed] [Google Scholar]
- 18.Theckumparampil N, Elsamra SE, Carons A, et al. Symptoms After Removal of Ureteral Stents. J Endourol. 2015;29(2):246–252. doi: 10.1089/end.2014.0432 [DOI] [PubMed] [Google Scholar]
- 19.Tadros NN, Bland L, Legg E, Olyaei A, Conlin MJ. A single dose of a non-steroidal anti-inflammatory drug (NSAID) prevents severe pain after ureteric stent removal: a prospective, randomised, double-blind, placebo-controlled trial. BJU Int. 2013;111(1):101–105. doi: 10.1111/j.1464-410X.2012.11214.x [DOI] [PubMed] [Google Scholar]
- 20.Johnson BA, Sorokin I, Antoelli J, and Pearle M. Efficacy of Ketorolac for Preventing Renal Colic Post Stent Removal: Randomized Controlled Trial. J Urol 2022. Sep;208(3)650–657. [DOI] [PubMed] [Google Scholar]
- 21.Kukreja JB, Schroeck FR, Lotan Y, et al. Discomfort and relieving factors among patients with bladder cancer undergoing office-based cystoscopy. Urol Oncol Semin Orig Investig. Published online June 2021:S1078143921002155. doi: 10.1016/j.urolonc.2021.05.009 [DOI] [PubMed] [Google Scholar]
- 22.Biardeau X, Lam O, Ba V, Campeau L, Corcos J. Prospective evaluation of anxiety, pain, and embarrassment associated with cystoscopy and urodynamic testing in clinical practice. Can Urol Assoc J. 2017;11(3–4):104–110. doi: 10.5489/cuaj.4127 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Richter M, Eck J, Straube T, Miltner WHR, Weiss T. Do words hurt? Brain activation during the processing of pain-related words. PAIN. 2010;148(2):198–205. doi: 10.1016/j.pain.2009.08.009 [DOI] [PubMed] [Google Scholar]
- 24.Lang EV, Hatsiopoulou O, Koch T, et al. Can words hurt? Patient–provider interactions during invasive procedures. PAIN. 2005;114(1):303–309. doi: 10.1016/j.pain.2004.12.028 [DOI] [PubMed] [Google Scholar]
- 25.Eberhardt J, van Wersch A, van Schaik P, Cann P. Information, social support and anxiety before gastrointestinal endoscopy. Br J Health Psychol. 2006;11(4):551–559. doi: 10.1348/135910705X72514 [DOI] [PubMed] [Google Scholar]
- 26.Felley C, Perneger TV, Goulet I, et al. Combined written and oral information prior to gastrointestinal endoscopy compared with oral information alone: a randomized trial. BMC Gastroenterol. 2008;8(1):22. doi: 10.1186/1471-230X-8-22 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Morgan M, Dodds W, Wolfe C, Raju S. Women’s views and experiences of outpatient hysteroscopy: Implications for a patient-centered service. Nurs Health Sci. 2004;6(4):315–320. doi: 10.1111/j.1442-2018.2004.00202.x [DOI] [PubMed] [Google Scholar]
- 28.Harper JD, Desai AC, Antonelli JA, Tasian GE et al. Quality of life impact and recovery after ureteroscopy and stent insertion: insights from daily surveys in STENTS. BMC Urol. 2022. Apr 6;22(1):53. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Harper JD, Desai AC, Maalouf NM, Yang H, et al. Risk Factors for Increased Stent-Associated Symptoms Following Ureteroscopy for Urinary Stones: Results from STENTS. J Urol 2023. doi: 10.1097/JU.0000000000003183 online ahead of print. [DOI] [PMC free article] [PubMed] [Google Scholar]
